MARCH Vascular Endothelium Substudy

CompletedOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Cardiovascular Disease
Interventions
DRUG

NRTI + PI

tenofovir zidovudine abacavir lamivudine emtricitabine ritonavir darunavir atazanavir lopinavir fosamprenavir

DRUG

maraviroc + PI

maraviroc ritonavir darunavir atazanavir lopinavir fosamprenavir

DRUG

maraviroc + NRTI

maraviroc tenofovir zidovudine abacavir lamivudine emtricitabine

Trial Locations (6)

2010

St. Vincent's Hospital, Sydney

10330

Chulalongkorn University Hospital, Bangkok

60590

Johann Wolfgang Goethe-University Hospital, Medical HIVCENTER, Frankfurt

C1221ADC

"Hospital General de Agudos Dr. José María Ramos Mejía", Buenos Aires

C1405CKC

Fundacion IDEAA, Buenos Aires

Unknown

Hospital Italiano de Buenos Aires, Buenos Aires

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Kirby Institute

OTHER_GOV

NCT01585753 - MARCH Vascular Endothelium Substudy | Biotech Hunter | Biotech Hunter